RxDoctor Payments Data

Kathryn Foy

Family · Fort Dodge, IANPI 1659093292

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,524in general payments, 2019–2025

Across 241 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$998
  • Sun Pharmaceutical Industries Inc.$554
  • Johnson & Johnson$495
  • E.r. Squibb & Sons, L.L.C.$441
  • UCB, Inc.$383
  • Dermavant Sciences, Inc.$251
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,13391%
  • Education$3919%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,524 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.

See all family providers in Iowa

Medicare billing

Part B allowed, 2024
$184,726
Medicare patients
900
Services billed
5,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab24$351,573
Cosentyx Sensoready (2 Pens)Secukinumab17$146,200
Enbrel SureclickEtanercept14$103,595
Dupixent SyringeDupilumab23$95,268
Clobetasol Propionate88$4,524
Tacrolimus25$2,544
Doxycycline Monohydrate74$2,072
Metronidazole32$1,455
Ketoconazole95$1,453
Betamethasone Dipropionate35$1,427
Clindamycin Phosphate18$1,034
Calcipotriene14$670
Imiquimod15$588
ValacyclovirValacyclovir Hcl15$539
Triamcinolone Acetonide57$509

Paid to pharmacies, not to this prescriber.

Other family in Fort Dodge

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →